Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ResMed, Inc.
ResMed beat Wall Street analysts’ projections for sales growth for the second quarter of 2021, announced exit of its portable oxygen market.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
2019 saw fewer revenue-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Belgian firm will float on Euronext Brussels; ResMed and Cochlear among existing investors who will invest in at least 25% of shares.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
- Curative Medical, Inc.
- HB Healthcare
- Inova Labs, Inc.
- Jaysec Technologies LLC
- Laboratories Narval
- Maribo Medico
- Propeller Health
- SleepScore Labs, Umbian
- Brightree LLC.